| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.651 | 71.179 | 82.144 | 98.819 | 114.133 | 237.431 | 267.391 | 280.315 | 250.506 | 259.401 |
| Total Income - EUR | 17.626 | 71.321 | 82.144 | 98.819 | 114.133 | 237.579 | 266.765 | 280.170 | 250.506 | 254.983 |
| Total Expenses - EUR | 14.132 | 58.373 | 60.912 | 81.272 | 100.208 | 197.906 | 231.207 | 240.666 | 226.391 | 232.543 |
| Gross Profit/Loss - EUR | 3.494 | 12.948 | 21.232 | 17.547 | 13.925 | 39.673 | 35.559 | 39.503 | 24.116 | 22.439 |
| Net Profit/Loss - EUR | 2.965 | 10.809 | 18.768 | 15.238 | 12.784 | 37.298 | 32.891 | 36.712 | 21.611 | 14.790 |
| Employees | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biocor Diagnostic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 28.434 | 19.676 | 10.759 | 2.852 |
| Current Assets | 11.328 | 26.942 | 42.140 | 48.620 | 48.856 | 71.766 | 66.556 | 80.841 | 68.171 | 84.116 |
| Inventories | 4.066 | 11.809 | 18.214 | 24.495 | 26.556 | 38.535 | 32.776 | 41.873 | 44.401 | 45.379 |
| Receivables | 5.272 | 9.510 | 16.263 | 12.301 | 15.035 | 15.058 | 26.681 | 36.370 | 21.064 | 34.234 |
| Cash | 1.990 | 5.622 | 7.663 | 11.823 | 7.266 | 18.173 | 7.100 | 2.598 | 2.706 | 4.503 |
| Shareholders Funds | 3.010 | 13.788 | 18.821 | 15.290 | 27.778 | 37.348 | 69.411 | 36.761 | 21.659 | 14.838 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.318 | 13.153 | 23.320 | 33.330 | 21.079 | 34.418 | 25.580 | 63.755 | 57.271 | 72.130 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Biocor Diagnostic Srl